期刊
CANCER GENE THERAPY
卷 28, 期 12, 页码 1376-1389出版社
SPRINGERNATURE
DOI: 10.1038/s41417-020-00285-2
关键词
-
类别
资金
- National Natural Science Fund [81672525]
- Project of Liaoning Distinguished Professor [[2012]145]
- Liaoning Natural Science Fund [201602830]
- Shenyang Plan Project of Science and Technology [F17-230-9-08]
- Shenyang clinical medicine research centre [[2017]76]
- China Medical University's 2017 discipline promotion programme [2017XK08]
- China Medical University's 2018 discipline promotion programme
The research found that LINC02446 may serve as a promising therapeutic target for bladder cancer treatment, affecting the proliferation, migration, and invasion of BC cells, and inhibiting the mTOR signaling pathway.
Accumulating evidence has been obtained to understand the mechanisms of long non-coding RNAs (lncRNAs) in bladder cancer (BC). However, due to the recurrence and metastasis of BC, searching for lncRNAs that are related to prognosis and metastasis and exploring the pathogenesis of BC might provide new insights for the treatment of BC. In the present study, we used the TCGA and GEO databases and identified LINC02446 as associated with prognosis and differentially expressed in bladder cancer tissues and para-cancer tissues. Then, we found that LINC02446 could affect the proliferation, migration and invasion of BC cells. Additionally, we found that LINC02446 could bind to the EIF3G protein and regulate the protein stability of EIF3G and then inhibit the mTOR signalling pathway. In summary, all these findings show that LINC02446 might serve as a promising therapeutic target for BC intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据